• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

275.0701 USD 2.0901 0.77%

As of 20:10:00 ET on 09/18/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 273.9700 High - Low: 275.0701 - 272.5800 Primary Exchange: NASDAQ GM
Volume: 449,140 52-Week Range: 191.2903 - 278.7800 Beta vs XNBI: 1.0002

ETF Chart for IBB

No chart data available.
  • IBB:US 274.8300
  • 1D
  • 1M
  • 1Y
272.9800
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-09-18) 275.0800
Assets (M) (on 2014-09-18) 5,419.0140
Shares out (M) 19.70
Market Cap (M) 5,418.88
% Premium -0.00
Average 52-Week % Premium -0.0005
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.14%

Performance for IBB

1-Month +3.63% 1-Year +30.82%
3-Month +10.34% 3-Year +40.97%
Year To Date +20.41% 5-Year +27.39%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 09/17/2014
Name Position Value % of Total
Gilead Sciences Inc 4,736,268 491,814,069 9.149%
Amgen Inc 3,316,092 466,607,305 8.680%
Celgene Corp 5,026,882 463,780,133 8.627%
Biogen Idec Inc 1,204,342 394,518,352 7.339%
Alexion Pharmaceuticals Inc 2,114,010 341,476,035 6.352%
Vertex Pharmaceuticals Inc 2,661,447 251,506,742 4.678%
Regeneron Pharmaceuticals Inc 626,521 224,983,691 4.185%
Illumina Inc 1,215,277 215,104,029 4.001%
Mylan Inc/PA 3,858,665 185,215,920 3.445%
Endo International PLC 1,752,845 119,631,671 2.225%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil